Tender notice from Bulgaria, published on 11 Mar 2020.
Executive Summary
The „МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ (МБАЛ) „Д-Р СТОЙЧО ХРИСТОВ“ ЕООД — СЕВЛИЕВО has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 11 Mar 2020 and is scheduled to close on 13 Apr 2020, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 41425887, while the tender notice number is 113210-2020 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33600000, 33600000 CPV Description: Pharmaceutical products. Delivery of medicinal products for the needs of "MBAL" Dr. Stoicho Hristov "Ltd., Sevlievo The order includes 156 nomenclature units in 12 positions, described in the technical specification. Main Site: Free warehouse of MBAL "Dr Stoycho Hristov" EOOD, Sevlievo city, 147 Stefan Peshev Str., hospital pharmacy The item includes the following 11 itemsrounds and estimated quantities: 1.1. A02BC01 Omeprazole powd.inj. 40 mg br 200 1.2. A03BA01 Atropine sulfates inj. 1 mg / ml - 1 ml 300 1.3. A06AA01 Liquid paraffin oral liq 40 g / liquid paraffin No. 20 1.4. A06AB05 Castor oil oral liquid 40 g br 20 1.5. A07BA01 Carbo activatus 250 mg - Tabl. tv 200 1.6. A10BB09 Gliclazide tb. modif. 60mg tv 210 1.7. A12AA03 Calcium gluconicum inj. 8.94 mg / ml - 10 ml Mar 2000 1.8. A12CC09 Magnesium orotate 500 mg (Magnerot) tv 600 1.9. A12CC30 Magnesium lactate 470 mg / Pyridoxine hydrate 5 mg (Magne B 6) tv 300 1.10. A12CC30 Magnesium lactate 650 mg / Pyridoxine hydrate 3 mg (Magnerich PLUS) tv 300 1.11. A16AA02 Ademetionine., Powd. inj. 500 mg solv, pcs. 800 1. Participants in this procedure may be registered traders under the Bulgarian legislationor under the law of a Member State of the European Union or a State Party to the EEA Agreement, which are entitled to wholesale the medicinal products for which they participate, within the meaning of Art. 195 and Art. 196 of the Law on Medicinal Products in Human Medicine / LPPHM /: A) Natural and legal persons authorized to wholesale medicinal products, issued by the regulatory authority of the Member State concerned who have been granted a wholesale marketing authorization for medicinal products by the Executive Director of the Executive Agency for Medicinal Products. . (C) Importer of medicinal products within the meaning of the CLPM for medicinal productsis the products for which they have been issued with an import permit. The participants must hold a valid: - Wholesale trade permit for medicinal products and / or - Certificate of registration for wholesale trade in the territory of the Republic of Bulgaria of the persons possessing authorization for this activity, issued by a regulatory authority of the Member State concerned and / or - Authorization to manufacture medicinestheir products and / or - Authorization to import the medicinal products for which the medicinal products participate, issued by the Executive Agency for Medicinal Products. 2. For participation in the nomenclature 9.1, 9.7, 9.8, 9.9, 9.14, 9.16 of Lot No 9, which are medicinal products containing narcotic substances, the participants must be registered traders under the Bulgarian legislation or under the lawnationality of an EU Member State or a State party to the EEA Agreement which are authorized to trade in medicinal products containing narcotic substances, in accordance with list II and III under art. 3 item 2 and item 3 of the Ordinance on the Procedure for Classification of Plants and Substances as Narcotic, under the Procedure of the Narcotic Substances and Precursors Control Act (LCNSP). The participantsmust have a license under Art. 32, para. 1 of the LCNSP. To prove the professional suitability, the participant shall provide (declare) in Part IV., Letter "A" of the Single European Public Procurement Document (EDES) information on the circumstances under item 3.1.- number and date of issue of wholesale trade permit and / or certificate of registration for wholesale trade in the territory of the Republic of Bulgaria onthe persons holding an authorization for this activity, issued by a regulatory body of the respective Member State and / or an authorization for the production and / or import of the medicinal products for which they apply, pursuant to the LPPMH, respectively the number and date of the license under Art. 32, para. 1 of the Narcotic Drugs and Precursors Control Act - if applicable. On the grounds of Art. 43 of the PDAB in the EDES presented itselfdata on public registers containing information on the declared circumstances or on the competent authority which, under the law of the respective country, is obliged to provide information on those circumstances ex officio to the contracting authority. presentation of all or part of the documents through which eprovide the information specified in the EDES, when necessary for the lawful conduct of the procedure. wholesale trade registration on the territory of the Republic of Bulgaria of the persons holding a permit for this activity, issued by the Republic of Bulgariaregulatory authority of the Member State concerned and / or authorization for the manufacture and / or import of medicinal products in accordance with the CLPM. - for nomenclature units: 9.1, 9.7, 9.8, 9.9, 9.14, 9.16 from Lot No 9 - certified copy of the license under Art. 32, para. 1 of the LCNSP. The contracting authority does not set. Continuation from field III.2.2) 4. Medicinal products obtained from human blood or human plasma, kas well as medicinal products containing narcotic substances should be included in the Positive Medicinal List. 6.Offered unit prices of the offered medicinal products should not exceed the reference (maximum) values determinedand at the date of the opening of the procedure Appendix No 2 to the Positive Medicinal List (PDL). I. A participant for whom any of the circumstances under Art. 54, para. 1 and Art. 55, para. 1, item 1 of the Public Procurement Act. The assignor will also exclude from participation in the procedure: • participants - related parties within the meaning of par. 2, item 45 of the PD of the Public Procurement Act;to participate in public procurement on the grounds of Art. 3, item 8 in conjunction with Art. 5, para. 1, item 3 of the Law on Economic and Financial Relations with the companies, registered in jurisdictions with preferential tax regime, the persons controlled by them and their real owners (ZIFODRIUDRTSLDS), unless the conditions under Art. 4 of the Law. • A participant who does not meet the criteriaSelection or failure to comply with any other condition set out in the contract notice or in the documentation; Art. 72, para 1 of PPA or whose offer was not accepted according to Art. 72, para. 3 5 of the Public Procurement Act; • a tenderer who does not respondt of the terms and conditions of submission, including form, method, term and validity. of the order higher than the estimated value of the order / lot. As in the case of a single price bid- higher than the value indicated in the "Reference value of 1 pc" column. a measure according to the PLS ", effective at the date of the opening of the procedure, for the relevant nomenclature. participant, for the same positionthe insider declares the lack of grounds for removal and compliance with the selection criteria by submitting to the EDES. II. On the main. Art. 47, para. 10 of the PDPA for the separate lots from the public procurement is allowed to submit one application for participation in the procedure. III. The contracting authority shall allow the submission of tenders under one or more lots. The tenderer may bid one, several or all nomenclature units included in the corresponding heading. IV. The contracting authority will require the designated contractor to provide a security guaranteeing the performance of the contract at a rate of 1 (one) percent of its value excluding VAT. The participant designated as the contractor chooses the form of the performance guarantee - cash, bank guarantee or insurance. V. Terms ofpayment deferred, within 60 calendar days, after the submission of the following documents: - invoice, prepared in accordance with the requirements of the VAT Act and the Regulations on VAT and original 1 / one / number certified copy - acceptance and delivery protocol The Client pays the goods actually delivered during the term of the contract and is not bound by the estimated quantities indicated in the documentation Internet address (URL): http://www.mbal-sevlievo.eu
The bid deadline for Contract notice: Pharmaceutical products was 13 Apr 2020. Bidding is closed.
This tender has been issued by „МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ (МБАЛ) „Д-Р СТОЙЧО ХРИСТОВ“ ЕООД — СЕВЛИЕВО in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 41425887. The purchaser document reference is 113210-2020.